Asterias Biotherapeutics
Why Robinhood?
You can watch AST and buy or sell other stocks, ETFs, and their options commission-free!About AST
Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer.
AST Key Statistics
Stock Snapshot
With a market cap of 92.97M, Asterias Biotherapeutics(AST) trades at $0.95. The stock has a price-to-earnings ratio of -3.54.
Asterias Biotherapeutics(AST) stock opened on 2026-03-14 at —. The price climbed to — and dipped to —.
Asterias Biotherapeutics(AST) shares are trading with a volume of 0, against a daily average of 81.23K.
During the past year, Asterias Biotherapeutics(AST) stock moved between $1.20 at its lowest and $3.75 at its peak.
During the past year, Asterias Biotherapeutics(AST) stock moved between $1.20 at its lowest and $3.75 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.